Global Stroke Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Description

The Stroke Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Stroke Therapeutics market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Ischemic Stroke accounting for  % of the Stroke Therapeutics global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Intravenous Injection segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Stroke Therapeutics include Abbott Laboratories, Cordis, Boston Scientific, Siemens, and Genentech, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Stroke Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Intravenous Injection
    Oral
    Others

Market segment by Application, can be divided into
    Ischemic Stroke
    Hemorrhagic Stroke
    Transient Ischemic Attack

Market segment by players, this report covers
    Abbott Laboratories
    Cordis
    Boston Scientific
    Siemens
    Genentech
    Koninklijke Philips
    Medtronic
    GE Healthcare
    Stryker
    Merck
    Zocere, Inc.
    Acticor Biotech
    DiaMedica Therapeutics
    Lumosa Therapeutics
    AXONIS Therapeutics , Inc.
    NovaGo Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Stroke Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Stroke Therapeutics, with revenue, gross margin and global market share of Stroke Therapeutics from 2019 to 2022.
Chapter 3, the Stroke Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Stroke Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Stroke Therapeutics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Stroke Therapeutics
    1.2 Classification of Stroke Therapeutics by Type
        1.2.1 Overview: Global Stroke Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Stroke Therapeutics Revenue Market Share by Type in 2021
        1.2.3 Intravenous Injection
        1.2.4 Oral
        1.2.5 Others
    1.3 Global Stroke Therapeutics Market by Application
        1.3.1 Overview: Global Stroke Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Ischemic Stroke
        1.3.3 Hemorrhagic Stroke
        1.3.4 Transient Ischemic Attack
    1.4 Global Stroke Therapeutics Market Size & Forecast
    1.5 Global Stroke Therapeutics Market Size and Forecast by Region
        1.5.1 Global Stroke Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Stroke Therapeutics Market Size by Region, (2017-2022)
        1.5.3 North America Stroke Therapeutics Market Size and Prospect (2017-2028)
        1.5.4 Europe Stroke Therapeutics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Stroke Therapeutics Market Size and Prospect (2017-2028)
        1.5.6 South America Stroke Therapeutics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Stroke Therapeutics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Stroke Therapeutics Market Drivers
        1.6.2 Stroke Therapeutics Market Restraints
        1.6.3 Stroke Therapeutics Trends Analysis

2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Stroke Therapeutics Product and Solutions
        2.1.4 Abbott Laboratories Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Cordis
        2.2.1 Cordis Details
        2.2.2 Cordis Major Business
        2.2.3 Cordis Stroke Therapeutics Product and Solutions
        2.2.4 Cordis Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Cordis Recent Developments and Future Plans
    2.3 Boston Scientific
        2.3.1 Boston Scientific Details
        2.3.2 Boston Scientific Major Business
        2.3.3 Boston Scientific Stroke Therapeutics Product and Solutions
        2.3.4 Boston Scientific Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Boston Scientific Recent Developments and Future Plans
    2.4 Siemens
        2.4.1 Siemens Details
        2.4.2 Siemens Major Business
        2.4.3 Siemens Stroke Therapeutics Product and Solutions
        2.4.4 Siemens Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Siemens Recent Developments and Future Plans
    2.5 Genentech
        2.5.1 Genentech Details
        2.5.2 Genentech Major Business
        2.5.3 Genentech Stroke Therapeutics Product and Solutions
        2.5.4 Genentech Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Genentech Recent Developments and Future Plans
    2.6 Koninklijke Philips
        2.6.1 Koninklijke Philips Details
        2.6.2 Koninklijke Philips Major Business
        2.6.3 Koninklijke Philips Stroke Therapeutics Product and Solutions
        2.6.4 Koninklijke Philips Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Koninklijke Philips Recent Developments and Future Plans
    2.7 Medtronic
        2.7.1 Medtronic Details
        2.7.2 Medtronic Major Business
        2.7.3 Medtronic Stroke Therapeutics Product and Solutions
        2.7.4 Medtronic Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Medtronic Recent Developments and Future Plans
    2.8 GE Healthcare
        2.8.1 GE Healthcare Details
        2.8.2 GE Healthcare Major Business
        2.8.3 GE Healthcare Stroke Therapeutics Product and Solutions
        2.8.4 GE Healthcare Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 GE Healthcare Recent Developments and Future Plans
    2.9 Stryker
        2.9.1 Stryker Details
        2.9.2 Stryker Major Business
        2.9.3 Stryker Stroke Therapeutics Product and Solutions
        2.9.4 Stryker Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Stryker Recent Developments and Future Plans
    2.10 Merck
        2.10.1 Merck Details
        2.10.2 Merck Major Business
        2.10.3 Merck Stroke Therapeutics Product and Solutions
        2.10.4 Merck Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Merck Recent Developments and Future Plans
    2.11 Zocere, Inc.
        2.11.1 Zocere, Inc. Details
        2.11.2 Zocere, Inc. Major Business
        2.11.3 Zocere, Inc. Stroke Therapeutics Product and Solutions
        2.11.4 Zocere, Inc. Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Zocere, Inc. Recent Developments and Future Plans
    2.12 Acticor Biotech
        2.12.1 Acticor Biotech Details
        2.12.2 Acticor Biotech Major Business
        2.12.3 Acticor Biotech Stroke Therapeutics Product and Solutions
        2.12.4 Acticor Biotech Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Acticor Biotech Recent Developments and Future Plans
    2.13 DiaMedica Therapeutics
        2.13.1 DiaMedica Therapeutics Details
        2.13.2 DiaMedica Therapeutics Major Business
        2.13.3 DiaMedica Therapeutics Stroke Therapeutics Product and Solutions
        2.13.4 DiaMedica Therapeutics Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 DiaMedica Therapeutics Recent Developments and Future Plans
    2.14 Lumosa Therapeutics
        2.14.1 Lumosa Therapeutics Details
        2.14.2 Lumosa Therapeutics Major Business
        2.14.3 Lumosa Therapeutics Stroke Therapeutics Product and Solutions
        2.14.4 Lumosa Therapeutics Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Lumosa Therapeutics Recent Developments and Future Plans
    2.15 AXONIS Therapeutics , Inc.
        2.15.1 AXONIS Therapeutics , Inc. Details
        2.15.2 AXONIS Therapeutics , Inc. Major Business
        2.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Product and Solutions
        2.15.4 AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 AXONIS Therapeutics , Inc. Recent Developments and Future Plans
    2.16 NovaGo Therapeutics
        2.16.1 NovaGo Therapeutics Details
        2.16.2 NovaGo Therapeutics Major Business
        2.16.3 NovaGo Therapeutics Stroke Therapeutics Product and Solutions
        2.16.4 NovaGo Therapeutics Stroke Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 NovaGo Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Stroke Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Stroke Therapeutics Players Market Share in 2021
        3.2.2 Top 10 Stroke Therapeutics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Stroke Therapeutics Players Head Office, Products and Services Provided
    3.4 Stroke Therapeutics Mergers & Acquisitions
    3.5 Stroke Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Stroke Therapeutics Revenue and Market Share by Type (2017-2022)
    4.2 Global Stroke Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Stroke Therapeutics Revenue Market Share by Application (2017-2022)
    5.2 Global Stroke Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Stroke Therapeutics Revenue by Type (2017-2028)
    6.2 North America Stroke Therapeutics Revenue by Application (2017-2028)
    6.3 North America Stroke Therapeutics Market Size by Country
        6.3.1 North America Stroke Therapeutics Revenue by Country (2017-2028)
        6.3.2 United States Stroke Therapeutics Market Size and Forecast (2017-2028)
        6.3.3 Canada Stroke Therapeutics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Stroke Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Stroke Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Stroke Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Stroke Therapeutics Market Size by Country
        7.3.1 Europe Stroke Therapeutics Revenue by Country (2017-2028)
        7.3.2 Germany Stroke Therapeutics Market Size and Forecast (2017-2028)
        7.3.3 France Stroke Therapeutics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Stroke Therapeutics Market Size and Forecast (2017-2028)
        7.3.5 Russia Stroke Therapeutics Market Size and Forecast (2017-2028)
        7.3.6 Italy Stroke Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Stroke Therapeutics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Stroke Therapeutics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Stroke Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Stroke Therapeutics Revenue by Region (2017-2028)
        8.3.2 China Stroke Therapeutics Market Size and Forecast (2017-2028)
        8.3.3 Japan Stroke Therapeutics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Stroke Therapeutics Market Size and Forecast (2017-2028)
        8.3.5 India Stroke Therapeutics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Stroke Therapeutics Market Size and Forecast (2017-2028)
        8.3.7 Australia Stroke Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Stroke Therapeutics Revenue by Type (2017-2028)
    9.2 South America Stroke Therapeutics Revenue by Application (2017-2028)
    9.3 South America Stroke Therapeutics Market Size by Country
        9.3.1 South America Stroke Therapeutics Revenue by Country (2017-2028)
        9.3.2 Brazil Stroke Therapeutics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Stroke Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Stroke Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Stroke Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Stroke Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Stroke Therapeutics Revenue by Country (2017-2028)
        10.3.2 Turkey Stroke Therapeutics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Stroke Therapeutics Market Size and Forecast (2017-2028)
        10.3.4 UAE Stroke Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Stroke Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Stroke Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Stroke Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Stroke Therapeutics Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Stroke Therapeutics Revenue Market Share by Region (2023-2028)
    Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
    Table 7. Abbott Laboratories Major Business
    Table 8. Abbott Laboratories Stroke Therapeutics Product and Solutions
    Table 9. Abbott Laboratories Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Cordis Corporate Information, Head Office, and Major Competitors
    Table 11. Cordis Major Business
    Table 12. Cordis Stroke Therapeutics Product and Solutions
    Table 13. Cordis Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Boston Scientific Corporate Information, Head Office, and Major Competitors
    Table 15. Boston Scientific Major Business
    Table 16. Boston Scientific Stroke Therapeutics Product and Solutions
    Table 17. Boston Scientific Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Siemens Corporate Information, Head Office, and Major Competitors
    Table 19. Siemens Major Business
    Table 20. Siemens Stroke Therapeutics Product and Solutions
    Table 21. Siemens Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Genentech Corporate Information, Head Office, and Major Competitors
    Table 23. Genentech Major Business
    Table 24. Genentech Stroke Therapeutics Product and Solutions
    Table 25. Genentech Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Koninklijke Philips Corporate Information, Head Office, and Major Competitors
    Table 27. Koninklijke Philips Major Business
    Table 28. Koninklijke Philips Stroke Therapeutics Product and Solutions
    Table 29. Koninklijke Philips Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Medtronic Corporate Information, Head Office, and Major Competitors
    Table 31. Medtronic Major Business
    Table 32. Medtronic Stroke Therapeutics Product and Solutions
    Table 33. Medtronic Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. GE Healthcare Corporate Information, Head Office, and Major Competitors
    Table 35. GE Healthcare Major Business
    Table 36. GE Healthcare Stroke Therapeutics Product and Solutions
    Table 37. GE Healthcare Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Stryker Corporate Information, Head Office, and Major Competitors
    Table 39. Stryker Major Business
    Table 40. Stryker Stroke Therapeutics Product and Solutions
    Table 41. Stryker Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Merck Corporate Information, Head Office, and Major Competitors
    Table 43. Merck Major Business
    Table 44. Merck Stroke Therapeutics Product and Solutions
    Table 45. Merck Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Zocere, Inc. Corporate Information, Head Office, and Major Competitors
    Table 47. Zocere, Inc. Major Business
    Table 48. Zocere, Inc. Stroke Therapeutics Product and Solutions
    Table 49. Zocere, Inc. Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Acticor Biotech Corporate Information, Head Office, and Major Competitors
    Table 51. Acticor Biotech Major Business
    Table 52. Acticor Biotech Stroke Therapeutics Product and Solutions
    Table 53. Acticor Biotech Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. DiaMedica Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 55. DiaMedica Therapeutics Major Business
    Table 56. DiaMedica Therapeutics Stroke Therapeutics Product and Solutions
    Table 57. DiaMedica Therapeutics Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Lumosa Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 59. Lumosa Therapeutics Major Business
    Table 60. Lumosa Therapeutics Stroke Therapeutics Product and Solutions
    Table 61. Lumosa Therapeutics Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. AXONIS Therapeutics , Inc. Corporate Information, Head Office, and Major Competitors
    Table 63. AXONIS Therapeutics , Inc. Major Business
    Table 64. AXONIS Therapeutics , Inc. Stroke Therapeutics Product and Solutions
    Table 65. AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 66. NovaGo Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 67. NovaGo Therapeutics Major Business
    Table 68. NovaGo Therapeutics Stroke Therapeutics Product and Solutions
    Table 69. NovaGo Therapeutics Stroke Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 70. Global Stroke Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 71. Global Stroke Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 72. Breakdown of Stroke Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 73. Stroke Therapeutics Players Head Office, Products and Services Provided
    Table 74. Stroke Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 75. Stroke Therapeutics New Entrants and Expansion Plans
    Table 76. Global Stroke Therapeutics Revenue (USD Million) by Type (2017-2022)
    Table 77. Global Stroke Therapeutics Revenue Share by Type (2017-2022)
    Table 78. Global Stroke Therapeutics Revenue Forecast by Type (2023-2028)
    Table 79. Global Stroke Therapeutics Revenue by Application (2017-2022)
    Table 80. Global Stroke Therapeutics Revenue Forecast by Application (2023-2028)
    Table 81. North America Stroke Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 82. North America Stroke Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 83. North America Stroke Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 84. North America Stroke Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 85. North America Stroke Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 86. North America Stroke Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 87. Europe Stroke Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 88. Europe Stroke Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 89. Europe Stroke Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 90. Europe Stroke Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 91. Europe Stroke Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 92. Europe Stroke Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 93. Asia-Pacific Stroke Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 94. Asia-Pacific Stroke Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 95. Asia-Pacific Stroke Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 96. Asia-Pacific Stroke Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 97. Asia-Pacific Stroke Therapeutics Revenue by Region (2017-2022) & (USD Million)
    Table 98. Asia-Pacific Stroke Therapeutics Revenue by Region (2023-2028) & (USD Million)
    Table 99. South America Stroke Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 100. South America Stroke Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 101. South America Stroke Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 102. South America Stroke Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 103. South America Stroke Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 104. South America Stroke Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 105. Middle East & Africa Stroke Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 106. Middle East & Africa Stroke Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 107. Middle East & Africa Stroke Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 108. Middle East & Africa Stroke Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 109. Middle East & Africa Stroke Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 110. Middle East & Africa Stroke Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Stroke Therapeutics Picture
    Figure 2. Global Stroke Therapeutics Revenue Market Share by Type in 2021
    Figure 3. Intravenous Injection
    Figure 4. Oral
    Figure 5. Others
    Figure 6. Stroke Therapeutics Revenue Market Share by Application in 2021
    Figure 7. Ischemic Stroke Picture
    Figure 8. Hemorrhagic Stroke Picture
    Figure 9. Transient Ischemic Attack Picture
    Figure 10. Global Stroke Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 11. Global Stroke Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Stroke Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 13. Global Stroke Therapeutics Revenue Market Share by Region in 2021
    Figure 14. North America Stroke Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Europe Stroke Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Asia-Pacific Stroke Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. South America Stroke Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Middle East and Africa Stroke Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Stroke Therapeutics Market Drivers
    Figure 20. Stroke Therapeutics Market Restraints
    Figure 21. Stroke Therapeutics Market Trends
    Figure 22. Abbott Laboratories Recent Developments and Future Plans
    Figure 23. Cordis Recent Developments and Future Plans
    Figure 24. Boston Scientific Recent Developments and Future Plans
    Figure 25. Siemens Recent Developments and Future Plans
    Figure 26. Genentech Recent Developments and Future Plans
    Figure 27. Koninklijke Philips Recent Developments and Future Plans
    Figure 28. Medtronic Recent Developments and Future Plans
    Figure 29. GE Healthcare Recent Developments and Future Plans
    Figure 30. Stryker Recent Developments and Future Plans
    Figure 31. Merck Recent Developments and Future Plans
    Figure 32. Zocere, Inc. Recent Developments and Future Plans
    Figure 33. Acticor Biotech Recent Developments and Future Plans
    Figure 34. DiaMedica Therapeutics Recent Developments and Future Plans
    Figure 35. Lumosa Therapeutics Recent Developments and Future Plans
    Figure 36. AXONIS Therapeutics , Inc. Recent Developments and Future Plans
    Figure 37. NovaGo Therapeutics Recent Developments and Future Plans
    Figure 38. Global Stroke Therapeutics Revenue Share by Players in 2021
    Figure 39. Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 40. Global Top 3 Players Stroke Therapeutics Revenue Market Share in 2021
    Figure 41. Global Top 10 Players Stroke Therapeutics Revenue Market Share in 2021
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 43. Global Stroke Therapeutics Revenue Share by Type in 2021
    Figure 44. Global Stroke Therapeutics Market Share Forecast by Type (2023-2028)
    Figure 45. Global Stroke Therapeutics Revenue Share by Application in 2021
    Figure 46. Global Stroke Therapeutics Market Share Forecast by Application (2023-2028)
    Figure 47. North America Stroke Therapeutics Sales Market Share by Type (2017-2028)
    Figure 48. North America Stroke Therapeutics Sales Market Share by Application (2017-2028)
    Figure 49. North America Stroke Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 50. United States Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Canada Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Mexico Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Europe Stroke Therapeutics Sales Market Share by Type (2017-2028)
    Figure 54. Europe Stroke Therapeutics Sales Market Share by Application (2017-2028)
    Figure 55. Europe Stroke Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 56. Germany Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. France Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. United Kingdom Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Russia Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Italy Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Asia-Pacific Stroke Therapeutics Sales Market Share by Type (2017-2028)
    Figure 62. Asia-Pacific Stroke Therapeutics Sales Market Share by Application (2017-2028)
    Figure 63. Asia-Pacific Stroke Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 64. China Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Japan Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South Korea Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. India Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Southeast Asia Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Australia Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. South America Stroke Therapeutics Sales Market Share by Type (2017-2028)
    Figure 71. South America Stroke Therapeutics Sales Market Share by Application (2017-2028)
    Figure 72. South America Stroke Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 73. Brazil Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Argentina Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Middle East and Africa Stroke Therapeutics Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Stroke Therapeutics Sales Market Share by Application (2017-2028)
    Figure 77. Middle East and Africa Stroke Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 78. Turkey Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Saudi Arabia Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 80. UAE Stroke Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Companies Mentioned

Abbott Laboratories
Cordis
Boston Scientific
Siemens
Genentech
Koninklijke Philips
Medtronic
GE Healthcare
Stryker
Merck
Zocere, Inc.
Acticor Biotech
DiaMedica Therapeutics
Lumosa Therapeutics
AXONIS Therapeutics , Inc.
NovaGo Therapeutics